Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

3.12
Delayed Data
As of Feb 23
 +0.01 / +0.32%
Today’s Change
2.88
Today|||52-Week Range
5.18
-20.41%
Year-to-Date
No recent news for Brainstorm Cell Therapuetics Inc.

Today’s Trading

Previous close3.11
Today’s open3.14
Day’s range3.06 - 3.14
Volume17,193
Average volume (3 months)82,121
Market cap$58.6M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)-114.81%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.87

Competitors

 Today’s
change
Today’s
% change
IMMPImmutep Ltd0.000.00%
AEZSAEterna Zentaris Inc-0.01-0.53%
PRTOProteon Therapeutics...-0.10-4.35%
HTGMHTG Molecular Diagno...+0.17+3.59%
Data as of 4:00pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$5.0M
Net profit margin--

Profile

Sector
Electronic Technology
Industry
Computer Peripherals
President &
Chief Executive Officer
Chaim Lebovits
Chief Operating &
Medical Officer
Ralph Z. Kern
Corporate headquarters
Hackensack, New Jersey

Forecasts